CA2692341A1 - Use of a synergistic composition as a therapeutic agent or disinfectant - Google Patents

Use of a synergistic composition as a therapeutic agent or disinfectant Download PDF

Info

Publication number
CA2692341A1
CA2692341A1 CA002692341A CA2692341A CA2692341A1 CA 2692341 A1 CA2692341 A1 CA 2692341A1 CA 002692341 A CA002692341 A CA 002692341A CA 2692341 A CA2692341 A CA 2692341A CA 2692341 A1 CA2692341 A1 CA 2692341A1
Authority
CA
Canada
Prior art keywords
agent
composition
wound
quantities
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002692341A
Other languages
English (en)
French (fr)
Inventor
Barbara Krug
Sven Eggerstedt
Richard Bloss
Christiane Ostermeyer
Thomas Lisowsky
Karlheinz Esser
Frank Buerger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Multibind Biotec GmbH
Bode Chemie GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2692341A1 publication Critical patent/CA2692341A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002692341A 2007-06-28 2008-06-27 Use of a synergistic composition as a therapeutic agent or disinfectant Abandoned CA2692341A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007030103A DE102007030103A1 (de) 2007-06-28 2007-06-28 Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel
DE102007030103.2 2007-06-28
PCT/EP2008/005292 WO2009000551A1 (de) 2007-06-28 2008-06-27 Verwendung einer synergistischen zusammensetzung als therapeutisches mittel oder desinfektionsmittel

Publications (1)

Publication Number Publication Date
CA2692341A1 true CA2692341A1 (en) 2008-12-31

Family

ID=39817047

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002692341A Abandoned CA2692341A1 (en) 2007-06-28 2008-06-27 Use of a synergistic composition as a therapeutic agent or disinfectant

Country Status (7)

Country Link
US (1) US8557265B2 (enExample)
EP (2) EP2170398B1 (enExample)
JP (1) JP2010531320A (enExample)
CA (1) CA2692341A1 (enExample)
DE (1) DE102007030103A1 (enExample)
ES (1) ES2423730T3 (enExample)
WO (1) WO2009000551A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019172739A1 (es) * 2018-03-09 2019-09-12 Instituto Tecnológico José Mario Molina Pasquel y Henriquez Suspensión antiviral potencializadora para tratamiento de fibras y su método de preparación

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005020327A1 (de) * 2005-04-30 2006-11-09 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen
DE102008064481A1 (de) 2008-12-18 2010-08-12 Bode Chemie Gmbh Kombinierte Desinfektions- und Dekontaminationsmittel mit erhöhter Wirksamkeit
EP2481288A1 (en) 2011-01-26 2012-08-01 multiBIND biotec GmbH Synergistic disinfecting compositions with essential oils
DE102015113641A1 (de) 2015-08-18 2017-02-23 Bode Chemie Gmbh Desinfektionsmittel mit organischen Säuren
EP3355860A1 (de) * 2015-09-29 2018-08-08 Tecuro AG Stabilisierte antiseptische zubereitungen
US20200147259A1 (en) * 2017-07-20 2020-05-14 Wenceslao GÓMEZ-LÓPEZ Formulation comprising nanostructured, biocompatible and biocatalytic material for the treatment of wounds and infections
DE102024109695B3 (de) 2024-04-08 2025-03-06 Allvater Biosolutions GmbH Wasserlösliches Dekontaminationskonzentrat, Dekontaminationslösung, Herstellungsverfahren zur Herstellung einer Dekontaminationslösung sowie Bereitstellungsvefahren zur Bereitstellung eines Dekontaminationskonzentrats

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7007A (en) * 1850-01-08 Improvement in machinery for making cotton cordage
US3018A (en) * 1843-03-21 Coupling for qttilting-frames
FR2041M (fr) 1962-04-17 1963-09-30 Andre Anselme Marie Composition thérapeutique a propriétés cytotoxiques a base d'acide ascorbique et d'ions métalliques.
EP0046409A1 (en) 1980-08-20 1982-02-24 Erwin Günther Walliczek A process for the preparation of a solution of a cuprous complex; solutions of the cuprous complexes for use in the therapeutic treatment of the human or animal body; and a method of therapeutic treatment of a plant
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
JP3436760B2 (ja) * 1994-07-27 2003-08-18 ハーバート ピルグリム 超常磁性粒子
GB2292746A (en) * 1994-08-30 1996-03-06 John Peter Hugh Williamson Bleach compositions
DE69728379T2 (de) * 1996-01-31 2005-02-24 South Alabama Medical Science Foundation, Mobile Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten
DE19603653B4 (de) 1996-02-01 2004-02-12 Siemens Ag Sendestufe, insbesondere für ein fernbedienbares Diebstahlschutzsystem eines Kraftfahrzeugs
JP3853985B2 (ja) 1998-08-03 2006-12-06 有限会社 健康百二十才 鉄イオン含有殺菌液
MXPA01003507A (es) * 1998-10-08 2002-06-26 Hampar L Karagoezian Antimicrobiano sinergico, preparaciones dermatologicas y oftalmicas que contienen clorito y peroxido de hidrogeno.
EP1154804B1 (en) * 1999-02-26 2008-02-20 Johnson & Johnson Consumer Companies, Inc. Bioadhesive antibacterial wound healing composition
DE50104383D1 (de) * 2000-01-28 2004-12-09 Merck Patent Gmbh Benzofuranonderivate enthaltende formulierung zum schutz vor oxidativem stress
JP2002104974A (ja) * 2000-09-29 2002-04-10 Nichiban Co Ltd ハイドロゲル損傷皮膚治療剤
WO2002028187A1 (en) 2000-09-29 2002-04-11 The Procter & Gamble Company Allergen neutralization compositions
US20030185915A1 (en) * 2002-03-28 2003-10-02 Jaime Carlo Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor
GB0212405D0 (en) 2002-05-29 2002-07-10 Insignion Holdings Ltd Composition and its therapeutic use
JP4677192B2 (ja) * 2004-02-20 2011-04-27 株式会社オゾテック オゾン溶存グリセリン溶液の製造方法
US7115287B2 (en) * 2005-03-03 2006-10-03 F.L.M., L.L.C. Topical medicament and method of use
DE102005020327A1 (de) 2005-04-30 2006-11-09 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen
DE102005044361A1 (de) 2005-09-09 2007-03-15 Aesculap Ag & Co. Kg Antimikrobielles medizintechnisches Produkt, Verfahren zu seiner Herstellung und Verwendung
WO2007041230A2 (en) 2005-09-30 2007-04-12 Omp, Inc. Stable ascorbic acid compositions
DE102006018983A1 (de) * 2006-04-25 2007-10-31 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur effizienten Degradation und Inaktivierung von Proteinen und Nukleinsäuren bei erhöhten Temperaturen
DE102006049108B4 (de) * 2006-10-13 2019-05-02 Agxx Intellectual Property Holding Gmbh Bioaktive, rutheniumhaltige Beschichtungen, deren Verwendung und Verfahren zur Beschichtung einer Vorrichtung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019172739A1 (es) * 2018-03-09 2019-09-12 Instituto Tecnológico José Mario Molina Pasquel y Henriquez Suspensión antiviral potencializadora para tratamiento de fibras y su método de preparación

Also Published As

Publication number Publication date
ES2423730T3 (es) 2013-09-24
JP2010531320A (ja) 2010-09-24
DE102007030103A1 (de) 2009-01-02
US20100119566A1 (en) 2010-05-13
WO2009000551A1 (de) 2008-12-31
EP2170398B1 (de) 2013-05-15
EP2489370A1 (de) 2012-08-22
EP2170398A1 (de) 2010-04-07
US8557265B2 (en) 2013-10-15
WO2009000551A8 (de) 2009-07-23

Similar Documents

Publication Publication Date Title
US8557265B2 (en) Use of a synergistic composition as a therapeutic agent of disinfectant
Percival et al. Antiseptics for treating infected wounds: efficacy on biofilms and effect of pH
EP3351264B1 (en) Composition comprising protease, amylase and lipase
EP2763665B1 (en) Antimicrobial compositions and methods employing same
US8632823B2 (en) Treatment of infected tissues with hypochlorous acid
Bigliardi et al. An Asian perspective on povidone iodine in wound healing
CN103402509A (zh) 包含过氧α-酮羧酸的组合物及其生产方法和使用方法
US20180036410A1 (en) Antimicrobial Compositions of Aminoglycosidic Antibiotics and Zinc Ion Chelators Specifically Formulated for Enhanced Inhibition of Bacterial Colonization and Antibacterial Efficacy
WO2007100917A2 (en) Antimicrobials and related methods
RU2611046C2 (ru) Композиции с антибактериальной и ранозаживляющей активностью
US20100291168A1 (en) Antimicrobial formulations comprising a combination of a pyridine thiol and a bis-quinolinium salt
EP1635850B1 (en) Antimicrobial silver comprising silver
Roberts Antimicrobial agents used in wound care
CN104784164A (zh) 一种蛋白皮肤清洁消毒剂及其制备方法
Vachhrajani et al. Antiseptics and Local Antibiotics
RU2508104C2 (ru) Антисептическое средство с гемостатическим действием и способ его получения
Negash et al. Common Antiseptics: Mechanism Of Action And Its Uses In Animal
HK1257876B (en) Composition comprising protease, amylase and lipase

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130617

FZDE Discontinued

Effective date: 20150811